Skip to main content

Advertisement

Log in

Low body mass index as a risk factor of moderate to severe oral mucositis in oral cancer patients with radiotherapy

  • Short Communication
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

The association between body mass index (BMI) and oral mucositis in oral cancer patients receiving radiotherapy is unclear. This study examined whether low BMI could be a risk factor for oral mucositis in oral cancer patients receiving radiotherapy.

Methods

Between April 2007 and March 2011, a total of 33 inpatients with oral cancer receiving radiotherapy were recruited. They were followed from the beginning of radiotherapy to discharge from hospital. All patients had no mucositis when radiotherapy started. The odds ratio (OR) and 95 % confidence interval (CI) of BMI for incident grade 2 and grade 3 mucositis were calculated by use of univariable logistic regression models.

Results

All patients developed oral mucositis (grade 1 in 39.4 %, grade 2 in 30.3 %, grade 3 in 30.3 %), with the maximum grade occurring at an average of 32.4 days. Compared with normal BMI (≥22.0), the OR of low BMI (<22.0) for moderate to severe mucositis was 9.07 (95 % CI, 1.72-47.68).

Conclusions

Low BMI may be a risk factor of moderate to severe oral mucositis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Vera-Llonch M, Oster G, Hagiwara M, Sonis S (2006) Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma—risk factors and clinical consequences. Cancer 106:329–336

    Article  PubMed  Google Scholar 

  2. McCarthy GM, Awde JD, Ghandi H, Vincent M, Kocha WI (1998) Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncol 34:484–490

    Article  PubMed  CAS  Google Scholar 

  3. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, Komaroff E, Nalysnyk L, Zilberberg MD (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66:253–262

    Article  PubMed  Google Scholar 

  4. Ikebe T, Seki K, Nakamura S, Takenoshita Y, Nakayama H, Shinohara M, Shirasuna K (2005) Severity of oral mucositis correlates with the response of oral cancer to preoperative radiochemotherapy. Int J Oral Maxillofac Surg 34:642–645

    Article  PubMed  CAS  Google Scholar 

  5. Sonis ST (1998) Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 34:39–43

    Article  PubMed  CAS  Google Scholar 

  6. Logan RM, Gibson RJ, Sonis ST, Keefe DMK (2007) Nuclear factor-kappa B (NF-kappa B) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy. Oral Oncol 43:395–401

    Article  PubMed  CAS  Google Scholar 

  7. Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, Forastiere A, Ang KK (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26:3582–3589

    Article  PubMed  CAS  Google Scholar 

  8. Kazemian A, Kamian S, Aghili M, Hashemi FA, Haddad P (2009) Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial. Eur J Cancer Care 18:174–178

    Article  CAS  Google Scholar 

  9. Meyerhardt JA, Tepper JE, Niedzwiecki D, Hollis DR, McCollum AD, Brady D, O'Connell MJ, Mayer RJ, Cummings B, Willett C, Macdonald JS, Benson AB, Fuchs CS (2004) Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from intergroup trial 0114. J Clin Oncol 22:648–657

    Article  PubMed  Google Scholar 

  10. Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Benson AB, Macdonald JS, Fuchs CS (2003) Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 98:484–495

    Article  PubMed  Google Scholar 

  11. Raber-Durlacher JE, Weijl NI, Abu Saris M, de Koning B, Zwinderman AH, Osanto S (2000) Oral mucositis in patients treated with chemotherapy for solid tumors: a retrospective analysis of 150 cases. Support Care Cancer 8:366–371

    Article  PubMed  CAS  Google Scholar 

  12. Robien K, Schubert MM, Bruemmer B, Lloid ME, Potter JD, Ulrich CM (2004) Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. J Clin Oncol 22:1268–1275

    Article  PubMed  Google Scholar 

  13. Raber-Durlacher JE (1999) Current practices for management of oral mucositis in cancer patients. Support Care Cancer 7:71–74

    Article  PubMed  CAS  Google Scholar 

  14. Dreizen S (1990) Oral complications of cancer therapies. Description and incidence of oral complications. NCI Monogr 9:11–15

    PubMed  Google Scholar 

  15. Benoist S, Panis Y, Alves A, Valleur P (2000) Impact of obesity on surgical outcomes after colorectal resection. Am J Surg 179:275–281

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of Interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nobue Saito.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saito, N., Imai, Y., Muto, T. et al. Low body mass index as a risk factor of moderate to severe oral mucositis in oral cancer patients with radiotherapy. Support Care Cancer 20, 3373–3377 (2012). https://doi.org/10.1007/s00520-012-1620-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-012-1620-7

Keywords

Navigation